ArticleCancer management and research2025

Thymosin α1 Combined with PD-1/PD-L1 Inhibitor Plus Chemotherapy in Platinum-Resistant Recurrent Ovarian Cancer : A Retrospective Analysis.

Hong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.